Staphylococcus cohnii subspecies: Staphylococcus cohnii subsp. cohnii subsp. nov. and Staphylococcus cohnii subsp. urealyticum subsp. nov.
Two major subspecies of Staphylococcus cohnii, namely S. cohnii subsp. cohnii, from humans, and S. cohnii subsp. urealyticum, from humans and other primates, are described on the basis of a study of 14 to 25 strains and 18 to 33 strains, respectively. DNA-DNA hybridization studies conducted in our laboratory in 1983 (W. E. Kloos and J. F. Wolfshohl, Curr. Microbiol. 8:115-121, 1983) demonstrated that strains representing the different subspecies were significantly divergent. S. cohnii subsp. urealyticum can be distinguished from S. cohnii subsp. cohnii on the basis of its greater colony size; pigmentation; positive urease, beta-glucuronidase, and beta-galactosidase activities; delayed alkaline phosphatase activity; ability to produce acid aerobically from alpha-lactose; and fatty acid profile. The type strain of S. cohnii subsp. cohnii is ATCC 29974, the designated type strain of S. cohnii Schleifer and Kloos 1975b, 55. The type strain of S. cohnii subsp. urealyticum is ATCC 49330.
Kloos
W E
WE
Department of Genetics, North Carolina State University, Raleigh 27695.
Wolfshohl
J F
JF
D000818:Animals; D002473:Cell Wall / Q000737:chemistry; D004269:DNA, Bacterial; D005227:Fatty Acids / Q000378:metabolism; D006801:Humans; D007785:Lactose / Q000378:metabolism; D008826:Microbial Sensitivity Tests; D009693:Nucleic Acid Hybridization; D010457:Peptidoglycan / Q000032:analysis; D010858:Pigmentation; D011323:Primates / Q000382:microbiology; D013210:Staphylococcus / Q000145:classification* / Q000201:enzymology / Q000235:genetics / Q000378:metabolism; D013682:Teichoic Acids / Q000032:analysis
D004269:DNA, Bacterial; D005227:Fatty Acids; D010457:Peptidoglycan; D013682:Teichoic Acids; D007785:Lactose